Statins Alleviate Tumor Hypoxia in Prostate Cancer Models by Decreasing Oxygen Consumption: An Opportunity for...

Area of Science:

• Biochemistry
• Oncology
• Medical Physics

Background:

• Statins are known to decrease oxygen consumption rate (OCR) in normal cells.
• This suggests statins might impact cancer cell metabolism and tumor oxygenation.
• Hypothesis: Statins could decrease cancer cell OCR, alleviate tumor hypoxia, and radiosensitize tumors.

Purpose of the Study:

• To investigate the effect of statins on cancer cell oxygen consumption.
• To assess the impact of statins on tumor hypoxia and radiosensitivity.
• To evaluate statins as a potential adjuvant therapy for cancer treatment.

Main Methods:

• Oxygen consumption rate (OCR) assessed using Seahorse XF96 and EPR respirometry in PC-3 prostate cancer cells.
• Mitochondrial superoxide production measured by EPR.
• In vivo tumor oxygenation (pO2) measured by EPR oximetry in a PC-3 prostate cancer model.
• Tumors irradiated with a single 6 Gy dose after statin treatment.

Main Results:

• Simvastatin and fluvastatin significantly decreased PC-3 cancer cell OCR.
• Fluvastatin exposure increased mitochondrial superoxide levels.
• Statin treatment increased tumor oxygenation in the PC-3 model.
• Simvastatin did not sensitize tumors to radiation therapy despite reoxygenation.

Conclusions:

• Statins affect tumor metabolism and oxygenation.
• The impact on tumor growth, with or without irradiation, was limited.
• Statins may not be effective in radiosensitizing prostate cancer models.